Internal Medicine, Allergy & Immunology · Fort Worth, TX
NPI
1588691125
Since 2006
Specialty
Internal Medicine, Allergy & Immunology
Code 207RA0201X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1000 College Ave
Fort Worth, TX, 76104
Phone (817) 336-8855
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
63,362 services
Medicare patients, 2024
766
Average age 73
Drug cost, 2024
$2.4M
10,173 prescriptions
Company payments, 2025
$1,189
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James R Haden was code J2357 (injection, omalizumab, 5 mg), 17,955 times for 31 patients. In total James R Haden billed 63,362 services in 26 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 17,955 | 31 | $26.40 | $474K |
| 95004 Test - Miscellaneous | Office | 13,583 | 184 | $2.46 | $33K |
| 95165 Treatment - Miscellaneous | Office | 2,896 | 148 | $9.51 | $28K |
| 95117 Treatment - Miscellaneous | Office | 2,885 | 101 | $6.65 | $19K |
| 95024 Test - Miscellaneous | Office | 1,678 | 63 | $5.46 | $9,167 |
| 95115 Treatment - Miscellaneous | Office | 1,638 | 58 | $4.53 | $7,415 |
| 99213 Office E&M - Established | Office | 1,101 | 655 | $56.03 | $62K |
| 96401 Chemotherapy Administration | Office | 744 | 38 | $49.31 | $37K |
| 94060 Pulmonary Function Testing | Office | 547 | 358 | $25.00 | $14K |
| 96372 Injection Administration | Office | 316 | 199 | $9.23 | $2,918 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 316 | 199 | $0.09 | $27.01 |
| 99203 Office E&M - New | Office | 197 | 197 | $67.32 | $13K |
| 99214 Office E&M - Established | Office | 38 | 36 | $65.06 | $2,472 |
| 94010 Pulmonary Function Testing | Office | 36 | 34 | $18.66 | $672 |
| 99204 Office E&M - New | Office | 11 | 11 | $104.65 | $1,151 |
By year: 2022 $967K for 48,385 services; 2023 $1.1M for 58,233 services; 2024 $1.0M for 63,362 services.
Medicare prescription drug claims, 2024
In 2024, the drug James R Haden prescribed most often to Medicare patients was Montelukast Sodium, with 2,284 prescriptions and refills. In total James R Haden wrote 10,173 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 2,284 | 4,828 | 608 | $23K |
| Azelastine Hcl Generic | 1,023 | 1,812 | 395 | $40K |
| Fluticasone Propionate Generic | 1,015 | 2,241 | 438 | $19K |
| Levocetirizine Dihydrochloride Generic | 802 | 1,640 | 219 | $11K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 510 | 660 | 245 | $19K |
| Ipratropium Bromide Generic | 485 | 713 | 161 | $17K |
| Famotidine Generic | 393 | 729 | 124 | $4,773 |
| Prednisone Generic | 314 | 314 | 223 | $688 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 314 | 446 | 79 | $279K |
| Epinephrine Generic | 281 | 295 | 229 | $49K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 160 | 204 | 50 | $126K |
| Omeprazole Generic | 142 | 249 | 31 | $2,076 |
| Breo Ellipta Fluticasone/Vilanterol | 138 | 212 | 32 | $80K |
| Triamcinolone Acetonide Generic | 132 | 160 | 63 | $2,080 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 129 | 257 | 48 | $29K |
Brand drugs: 2,098 claims; generic drugs: 8,075 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James R Haden $1,189 ($1,189 in general payments such as food, travel and fees) from 19 companies. The largest payer was ARS Pharmaceuticals Operations, Inc. with $251.
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. SPRY | 7 | $251 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $112 |
| GlaxoSmithKline, LLC. GSK | 5 | $97.26 |
| Blueprint Medicines Corporation SNY | 3 | $81.17 |
| Ionis Pharmaceuticals, Inc. IONS | 3 | $80.96 |
| Genzyme Corporation SNY | 3 | $79.14 |
| CSL Behring CSL.AX | 3 | $76.48 |
| LEO Pharma Inc. | 3 | $54.64 |
| Incyte Corporation INCY | 2 | $48.17 |
| Azurity Pharmaceuticals, Inc. | 2 | $45.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.